Date: 2013-04-22
Type of information: R&D agreement
Compound: undisclosed
Company: Evotec (Germany) Genentech, a member of Roche group (USA - Switzerland)
Therapeutic area: undisclosed
Type agreement: R&D
Action mechanism:
Disease: undisclosed
Details: * On April 22, 2013, Evotec has announced that it has extended its drug discovery alliance with Genentech, for three additional years. The collaboration was initiated in May 2010 and this extension further validates Evotec’s technology platform and broad expertise in drug discovery.
Financial terms:
Latest news:
